BioPlex 2200 Autoimmune Test Menu
The BioPlex 2200 System includes a comprehensive menu of assays to aid in the diagnosis of autoimmune diseases. Multiplex technology enables simultaneous detection and identification of the most clinically relevant autoantibodies. Laboratories can manage rising test volumes while reducing operational costs with a single fully automated solution.
Streamline Autoimmune Testing Workflow
Traditional autoimmune testing often involves multiple tests, managing intricate testing algorithms that include sequential follow-up testing, or outsourcing to reference labs. But with the multiplex autoimmune test menu of the BioPlex 2200 System, your lab can bring testing in house, achieve unparalleled workflow and process efficiency, and deliver more results faster.
Expand In-House Autoimmune Testing
Reduce dependence on expensive, time-consuming send-out testing and dramatically enhance your lab’s workflow and turnaround time.
Consolidate Test Methods
Minimize the number of tests, QC runs, and calibration runs. Eliminate follow-up testing and simplify management of testing algorithms. Consolidating testing onto a single analyzer means less waste and more process efficiency.
Improve Result Throughput
With the BioPlex 2200 ANA Screen, you can generate up to 14 results per test and deliver up to 1,400 results per hour.*
Take Lab Efficiency to the Next Level
Consolidate autoimmune and infectious disease testing onto a single high-throughput multiplex analyzer.
* Up to 12 results per test and 1,200 results per hour in the U.S.
Do More with Less: Autoimmune Multiplexing
See how your clinical laboratory can handle growing autoimmune testing volumes, rein in operational costs, and improve patient care. The fully automated BioPlex 2200 System uses multiplex technology to detect and differentiate multiple individual autoantibody analytes in a single test.
Autoimmune Multiplex Panels
BioPlex 2200 autoimmune multiplex panels aid clinicians in diagnosing patients with connective tissue diseases, vasculitis, rheumatoid arthritis, antiphospholipid syndrome (APLS), and celiac disease.
ANA Screen with MDSS
Detects and differentiates up to 13 clinically relevant antinuclear antibodies to aid in the diagnosis of connective tissue diseases. The MDSS Software may be used to associate positive ANA result profiles with specific connective tissue diseases.
Vasculitis Kit
Detects and differentiates clinically relevant antibodies (anti-MPO, anti-PR3 and anti-GBM) associated with small vessel vasculitis and the renal disorder Goodpasture's syndrome.
Celiac Kits
Enable semi-quantitative detection of IgA or IgG autoantibodies to tissue transglutaminase (tTG) and deamidated gliadin peptide (DGP), aiding in the diagnosis of celiac disease. Samples with deficient IgA levels are flagged.
APLS Kits
Enable semi-quantitative detection of IgA or IgG autoantibodies to tissue transglutaminase (tTG) and deamidated gliadin peptide (DGP), aiding in the diagnosis of celiac disease. Samples with deficient IgA levels are flagged.
Anti-CCP Kit
Enables the semi-quantitative detection of IgG antibodies to cyclic citrullinated peptide (CCP) in human serum and EDTA or heparinized plasma. Aids in diagnosis of rheumatoid arthritis.
Key Challenges of Autoimmune Testing
Traditional autoimmune testing often involves many individual antibody tests and management of sequential testing algorithms. Multiple test methods and manual processes put a strain on limited laboratory staffing resources while hindering result throughput and turnaround time. These challenges are compounded by constant pressure to manage costs while increasing revenue.
Maximize Clinical Laboratory Value
Concerned about the cost of autoimmune testing? Learn how an extensive multiplex autoimmune test menu empowers labs to minimize costs and maximize revenue.
Minimize Costs
- Testing Costs: By combining automation and multiplexing, you can deliver more results with fewer tests and less reagent handling, saving significant testing costs.
- Send-Out Costs: Bring an entire class of testing in house and reduce send-out expenses and associated operational costs.
- Testing Failure Costs: Minimize human errors, avoid testing failures, and detect and resolve errors quickly with integrated QC technology.
Maximize Revenue
- New Clinicians: Attract clinicians with a comprehensive autoimmune test menu.
- Reimbursements: Add high-reimbursement autoimmune testing capabilities to dramatically increase your lab’s testing volume and range.
- Revenue Streams: Diversify revenue streams with fully automated multiplex panels.
Improve Patient Care
An extensive autoimmune test menu, incorporating the latest in multiplex technology, can help you deliver clinically relevant results with remarkable speed and unparalleled quality assurance.
Result Turnaround Time
By generating multiple autoimmune results in a single test, multiplexing expedites turnaround time for patient results. This accelerates test processing — particularly for test panels with follow-up algorithms — leading to faster diagnoses and better patient outcomes.
Integrated Quality Assurance
Quality control beads unique to the BioPlex 2200 System are integrated into every test, enabling real-time analysis of assay parameters.
This ensures confidence in every patient result.
- Serum Verification Bead (SVB) verifies the addition of serum or plasma in every test
- Reagent Blank Bead (RBB) identifies sample problems arising from non-specific binding
- Internal Standard Bead (ISB) monitors detector fluctuations
- IgA Verification Bead (AVB) detects IgA deficiency in the Celiac IgA Kit